Product description
Prescription medications
See a list of details to help identify the product.
Reason the product is recalled
The products have been supplied in containers without child-resistant closures. Please note that there is no concern regarding the quality or safety of this medicine other than the absence of child resistant packaging.
The hazards to consumers
If children gain access to the products there is the potential for inadvertent poisoning.
What consumers should do
Consumers are asked to consult their physician on an alternate treatment and then return the product to the place of purchase for a full refund.
Details to help identify the product.
Supplier running the recall
Pfizer Australia Pty Ltd
Who sold the product
Various Pharmacies nationwide
Identifying product features
HALCION (triazolam) & PONSTAN (mefenamic acid) & XANAX (alprazolam) - All Batches
HALCION (triazolam) 0.125 mg tablets, Bottles of 50 AUST R number: 12304
PONSTAN (mefenamic acid) 250 mg capsules, Bottles of 50 AUST R number: 14387
XANAX (alprazolam) 2mg Tablets, Bottles of 50 AUST R number: 53931 (Discontinued December 2013)
Identifying numbers
Other identifying numbers
HALCION (triazolam) & PONSTAN (mefenamic acid) & XANAX (alprazolam) - All Batches
HALCION (triazolam) 0.125 mg tablets, Bottles of 50 AUST R number: 12304
PONSTAN (mefenamic acid) 250 mg capsules, Bottles of 50 AUST R number: 14387
XANAX (alprazolam) 2mg Tablets, Bottles of 50 AUST R number: 53931 (Discontinued December 2013)
HALCION (triazolam) 0.125 mg tablets, Bottles of 50 AUST R number: 12304
PONSTAN (mefenamic acid) 250 mg capsules, Bottles of 50 AUST R number: 14387
XANAX (alprazolam) 2mg Tablets, Bottles of 50 AUST R number: 53931 (Discontinued December 2013)
Where the product was sold
Nationally
Responsible regulators
Regulators are established or appointed by government. They enforce regulations and rules.
Quote PRA number 2015/14593 when contacting a regulator about this recall.
Recall and remedy questions
Contact the Therapeutic Goods Administration if you have:
- a question about the remedy being offered to you by the business that is responsible for managing this recall, or
- concerns about the way the business is managing this recall.